Risk Evaluation and Mitigation Strategies for US Drug Development, Second Edition
Books Member:
$37.50 Nonmember:
$62.50 APIsAudit/inspectionBiologics/ biosimilars/ vaccinesBiotechnologyCombination products/companion diagnosticsComplianceDiagnostics/IVDsNorth AmericaNutritional/Natural HealthOTCOtherPharmaceuticalsRegulatory Intelligence/Policy